Northwest Bioth Cmn (NWBO): Price and Financial Metrics

NWBO POWR Grades

• Growth is the dimension where NWBO ranks best; there it ranks ahead of 56.78% of US stocks.
• NWBO's strongest trending metric is Value; it's been moving up over the last 179 days.
• NWBO's current lowest rank is in the Momentum metric (where it is better than 4.64% of US stocks).

NWBO Stock Summary

• With a price/earnings ratio of 3.74, Northwest Biotherapeutics Inc P/E ratio is greater than that of about only 3.26% of stocks in our set with positive earnings.
• With a price/sales ratio of 665.81, Northwest Biotherapeutics Inc has a higher such ratio than 99.31% of stocks in our set.
• NWBO's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 5.36% of US stocks.
• Stocks that are quantitatively similar to NWBO, based on their financial statements, market capitalization, and price volatility, are QLYS, BOX, LYFT, PACB, and MPWR.
• NWBO's SEC filings can be seen here. And to visit Northwest Biotherapeutics Inc's official web site, go to www.nwbio.com.

NWBO Valuation Summary

• NWBO's price/earnings ratio is -2.4; this is 106.58% lower than that of the median Healthcare stock.
• Over the past 239 months, NWBO's price/sales ratio has gone up 173.7.
• NWBO's price/sales ratio has moved up 173.7 over the prior 239 months.

Below are key valuation metrics over time for NWBO.

NWBO Growth Metrics

The year over year price growth rate now stands at 413.16%.
• Its 3 year net income to common stockholders growth rate is now at 42.34%.
• The 4 year cash and equivalents growth rate now stands at -93.86%.

Over the past 52 months, NWBO's revenue has gone up $630,000.

The table below shows NWBO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	1.005	-38.299	179.126
2021-09-30	1.508	-37.256	-234.493
2021-06-30	1.374	-38.265	-474.108
2021-03-31	0.96	-37.802	-536.47
2020-12-31	1.291	-32.093	-529.821
2020-09-30	1.685	-27.868	-242.649

NWBO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• NWBO has a Quality Grade of C, ranking ahead of 27.35% of graded US stocks.
• NWBO's asset turnover comes in at 0.045 -- ranking 328th of 682 Pharmaceutical Products stocks.
• EDSA, BLCM, and GLYC are the stocks whose asset turnover ratios are most correlated with NWBO.

The table below shows NWBO's key quality metrics over time.